跳至主要内容
临床试验/NCT01729208
NCT01729208已完成不适用

A Multicentre Dispensing Clinical Evaluation of MiSight® Lenses

Coopervision, Inc.8 个研究点 分布在 4 个国家目标入组 144 人开始时间: 2012年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
144
试验地点
8
主要终点
Change in Refractive Error Relative to Baseline

研究概览

简要总结

The purpose of this study is to determine whether a new type of soft contact lens with a unique optical design (dual focus) is effective at slowing the progression of myopia (near-sightedness) in children.

详细描述

Subjects were randomized to wear test or control soft contact lens to determine whether a new type of soft contact lens with a unique optical design (dual focus) is effective at slowing the progression of myopia (near-sightedness) in children.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
8 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Be between 8 and 12 years of age inclusive.
  • Best-corrected visual acuity by manifest refraction of +0.10 logMAR.
  • Spherical Equivalent Refractive Error between -0.75 and -4.00 D
  • inclusive astigmatism: < -0.75 D and anisometropia: < 1.00 D
  • Possess wearable and visually functional eyeglasses.
  • Agree to wear the assigned contact lenses for a minimum of 10 hours per day, - at least 6 days per week, for the duration of the 3 year study.

排除标准

  • Subject has previously or currently wears contact lenses or rigid gas permeable contact lenses, including orthokeratology lenses.
  • Subject is currently or within 30 days prior to this study has been an active participant in another clinical study.
  • Current or prior use of bifocals, progressive addition lenses, atropine, pirenzepine or ANY other myopia control treatment.
  • Regular use of ocular medications (prescription or over-the-counter), artificial tears, or wetting agents.
  • Current use of systemic medications which may significantly affect contact lens wear, tear film production, pupil size, accommodation or refractive state.
  • A known allergy to fluorescein, benoxinate, proparacaine or tropicamide.
  • Strabismus by cover test at far (4 m) or near (40 cm) wearing distance correction.
  • Any ocular, systemic or neuro-developmental conditions that could influence refractive development.

结局指标

主要结局

Change in Refractive Error Relative to Baseline

时间窗: 36 months

Mean change in refractive error, measured with cycloplegic auto-refraction in Diopters at 36 months, relative to baseline.

Change in Axial Length Relative to Baseline

时间窗: 36 months

Mean change in axial length measurement, in millimeters at 36 months, relative to baseline.

次要结局

  • Number of Participants With Biomicroscopic Findings Greater Than Grade 2(12 months)
  • Number of Participants With Biomicroscopic Findings(24 months)
  • Number of Participants With Biomicroscopic Findings Greater Than Grade 2.(36 months)
  • Incidence of Adverse Events(36 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

An Evaluation of the Effectiveness of Dual Focus... | 临床试验